NEW PRODUCT: CHIOS MASTIHA POWDER – mastiha var. Chia

28/11/2023|All articles, Exploiting the gifts of Greek nature, Press Room, Product launches|

Launching  the new Chios Mastiha in Powder (package of 15 sachets) expands the well-established Mastiha var.Chia brand. Dr. Christos Kon. Zavos, Gastroenterologist – Hepatologist introduced the product to PharmaQ sales force at the new facilities of Iasis Pharma in Koropi. Dr. Christos Kon. Zavos presented all the Updated Facts, Important Scientific Data & Newest Developments [...]

NEW PRODUCT LAUNCH: Qpain®

16/10/2023|All articles, Product launches|

Qpain® is a new topical anti-inflammatory cutaneous solution, containing diclofenac sodium 1.5% w/w, indicated for the symptomatic relief of pain associated with osteoarthritis in superficial joints, including the knee. – Qpain® contains DMSO which enhances the absorption of diclofenac from the skin and reaches the focus of pain and inflammation directly. Ideal for those who cannot [...]

NEW PRODUCT LAUNCHING: Nitrofurantoin/IASIS® oral susp. – 1st Choice, Prevention & Treatment of UTIs

29/06/2023|All articles, Press Room, Product launches|

IASIS PHARMA is pleased to announce the Nitrofurantoin/IASIS oral susp. launching in the oral suspension formulation. This Innovative Pharmaceutical Form is a global market leader. This dosage form is Research and Development by IASIS PHARMA HELLAS S.A. Each 5ml of oral suspension Nitrofurantoin/IASIS oral susp. contains 25mg of Nitrofurantoin monohydrate which, according to international literature, [...]

NEW PRODUCT LAUNCH: ETROZAC®

20/09/2021|All articles, Product launches|

IASIS PHARMA is pleased to announce the release of its new product ETROZAC®. ETROZAC® active substance is etoricoxib which is a selective cox-2 inhibitor. ETROZAC® is indicated for the relief of the symptoms of Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis and the pain and symptoms of inflammation associated with Acute Gout. ETROZAC® is indicated for the [...]

NEW PRODUCT LAUNCH: Rami – Amlo plus®

17/09/2021|All articles, Product launches|

IASIS PHARMA is pleased to announce the release of the new product Rami – Amlo plus® Rami – Amlo plus® is an original (prototype) fixed dose combination of Ramipril – Amlodipine -Hydrochlorothiazide Rami – Amlo plus® is indicated for the treatment of hypertension. Available in packs of 30 capsules, in a wide dosage range: Rami [...]

COVED® NEW PRODUCT LAUNCH

23/04/2021|All articles, Product launches|

IASIS PHARMA has successfully launched COVED® to the Greek market. COVED® (Bisphosphonates, combinations) is a fixed dose combination of two active ingredients: Alendronic acid (as alendronate sodium trihydrate) (70mg) & Cholecalciferol (Vitamin D3) (5.600 I.U). COVED® 70 mg / 5,600 IU is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D [...]

GLUCOPLUS®1.000mg NEW 60 F.C. TABS PACKAGE

05/04/2021|All articles, Product launches|

IASIS PHARMA is pleased to announce the launch of the new 60 f.c. tabs packaging for GLUCOPLUS® 1.000mg (Metformin hydrochloride). Both GLUCOFREE® & GLUCOPLUS® (active ingredient: metformin hydrochloride) belong to the broader category of Oral Hypoglycemic Agents (OHAs) for the treatment of Type 2 Diabetes Mellitus (T2D) as first-line therapy. GLUCOFREE® is available in 850mg metformin hydrochloride, [...]

SENSIBIO 30® g. NEW PACKAGE

09/11/2020|All articles, Product launches|

IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Sensibio® in 30 g. new package. Sensibio® 30 g. new package was launched to the market in order to complete Sensibio® 15 g., the well-established fixed combination of Fusidic acid (antibiotic) and [...]

FLUSTERIX® 30 g. NEW PACKAGE

09/11/2020|All articles, Product launches|

IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Flusterix® in 30 g. new package. Flusterix® 30 g. was launched in order to complete the, well-established to the pharmaceutical market, Flusterix® 15 g. package. Flusterix® has Fusidic acid as its active ingredient, [...]

GLUCOFREE® & GLUCOPLUS® NEW PRODUCTS LAUNCH

04/06/2019|All articles, Product launches|

IASIS PHARMA proudly announces the addition of Glucofree® & Glucoplus® to its wide product portfolio. Glucofree® & Glucoplus® have metformin hydrochloride as their active ingredient and they belong to OHAs (Oral Hypoglycemic Agents). Metformin’s therapeutic indication is type 2 diabetes, especially on obese patients when the imposed diet and body exercise are not enough to [...]

Load More Posts